Growth Equity Opportunities Fund III LLC 13D and 13G filings for Aurinia Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-03-10 9:41 pm Sale |
2021-02-24 | 13D | Aurinia Pharmaceuticals Inc. AUPH |
Growth Equity Opportunities Fund III LLC | 0 0.000% |
-5,593,342 (Position Closed) |
Filing |